Utility of semi-quantitative quick cortisol assay with low-dose adrenocorticotropic hormone infusion adrenal vein sampling

ANZ J Surg. 2022 Mar;92(3):437-442. doi: 10.1111/ans.17352. Epub 2021 Nov 21.

Abstract

Background: Adrenal vein sampling (AVS) is integral to identifying surgically remediable unilateral primary aldosteronism (PA). However, right adrenal vein (AV) cannulation can be challenging, limiting its success. Intra-procedural cortisol assays can improve the reliability of AVS. The aim of this study was to validate the use of semi-quantitative cortisol estimates obtained utilizing a quick cortisol assay (QCA) during AVS procedures at our institution.

Methods: Retrospective review of results of AVS procedures before and after the introduction of the QCA. Twenty-three AVS procedures were performed with the provisional success determined by intra-procedural QCA. Successful AV cannulation was defined by an AV to peripheral vein cortisol ratio ≥ 4.0 (the selectivity index) from laboratory measurements. The control cohort consisted of 23 consecutive procedures prior to introduction of the QCA.

Results: QCA correctly predicted all AV cannulation attempts. Successful bilateral AV cannulation increased from 52% to 91% of procedures when performed with the QCA (P = 0.01) and adequate cannulation of the right AV increased from 61% to 91% (P = 0.03). There was no increase in procedural time, number of AV cannulation or sampling attempts.

Conclusions: Point-of-care, semi-quantitative cortisol estimates can be performed accurately during AVS with QCA, facilitating improvements in AVS success rates without increasing procedural time.

Keywords: AVS; hyperaldosteronism; intra-procedural cortisol assay; quick cortisol assay.

MeSH terms

  • Adrenal Glands
  • Adrenocorticotropic Hormone
  • Humans
  • Hydrocortisone*
  • Hyperaldosteronism* / diagnosis
  • Hyperaldosteronism* / surgery
  • Reproducibility of Results
  • Retrospective Studies

Substances

  • Adrenocorticotropic Hormone
  • Hydrocortisone